Literature DB >> 7591391

Neuromuscular differences between volleyball players, middle distance runners and untrained controls.

G G Sleivert1, R D Backus, H A Wenger.   

Abstract

Volleyball players, middle distance runners and non-athletes (n = 10/group) were tested to determine whether neuromuscular differences existed between groups and to clarify the roles of factors involved in maximal power production. The runners were leaner than controls, while the volleyball players were taller, heavier and had larger thigh volumes than the other groups. The volleyball players had higher absolute cycle ergometer power than both middle distance (26%) and control (15%) groups, but differences disappeared when expressed relative to body mass or thigh volume. Volleyball athletes were also stronger than both middle distance (51, 52%) and control subjects (33, 35%) for isokinetic leg extension and plantar flexion respectively (0-4.19 rad.s-1). In leg press they were stronger than middle distance (32%) and control subjects (36%) for only the isometric and 1.05 rad.s-1 contraction. The volleyball players also had higher rates of isometric torque development than the other groups, however nerve conduction velocity did not vary. Vastus lateralis biopsy samples revealed no differences in percent Type II muscle fibers, or fiber cross-sectional area between groups, yet volleyball athletes had larger Type II/I fiber area ratio than controls (15%). Both strength, rate of torque development and power were related to muscle and muscle fiber size variables, but not fiber distribution or nerve conduction velocity. The size of type II muscle fibers seemed to be especially important since this was the only variable related to power when adjusted for body size.

Entities:  

Mesh:

Year:  1995        PMID: 7591391     DOI: 10.1055/s-2007-973026

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  15 in total

Review 1.  Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering.

Authors:  A Ross; M Leveritt
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 2.  Neural influences on sprint running: training adaptations and acute responses.

Authors:  A Ross; M Leveritt; S Riek
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Muscle strength testing: evaluation of tests of explosive force production.

Authors:  Dragan M Mirkov; Aleksandar Nedeljkovic; Sladjan Milanovic; Slobodan Jaric
Journal:  Eur J Appl Physiol       Date:  2003-10-02       Impact factor: 3.078

Review 4.  Muscle strength testing: use of normalisation for body size.

Authors:  Slobodan Jaric
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  Movement performance and body size: the relationship for different groups of tests.

Authors:  Goran Markovic; Slobodan Jaric
Journal:  Eur J Appl Physiol       Date:  2004-03-16       Impact factor: 3.078

6.  Do neuromuscular adaptations occur in endurance-trained boys and men?

Authors:  Rotem Cohen; Cam Mitchell; Raffy Dotan; David Gabriel; Panagiota Klentrou; Bareket Falk
Journal:  Appl Physiol Nutr Metab       Date:  2010-08       Impact factor: 2.665

Review 7.  Effects of physical training and detraining, immobilisation, growth and aging on human fascicle geometry.

Authors:  Anthony J Blazevich
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

8.  Rate of muscle activation in power- and endurance-trained boys.

Authors:  Cameron Mitchell; Rotem Cohen; Raffy Dotan; David Gabriel; Panagiota Klentrou; Bareket Falk
Journal:  Int J Sports Physiol Perform       Date:  2011-03       Impact factor: 4.010

9.  Neuromuscular and electromechanical properties of ultra-power athletes: the traceurs.

Authors:  Sidney Grosprêtre; Philippe Gimenez; Alain Martin
Journal:  Eur J Appl Physiol       Date:  2018-04-20       Impact factor: 3.078

10.  Motor asymmetry in elite fencers.

Authors:  Selcuk Akpinar; Robert L Sainburg; Sadettin Kirazci; Andrzej Przybyla
Journal:  J Mot Behav       Date:  2014-12-12       Impact factor: 1.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.